![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Acta Anaesthesiol Scand |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Posterior quadratus lumborum block versus epidural analgesia for postoperative
pain management after open radical cystectomy: a randomized clinical trial.
Acta Anaesthesiol Scand. 2022 Dec 22. doi: 10.1111/aas.14188.
PubMed
Abstract available
URINARY BLADDER CANCER RECURRENCE AND EXPRESSION OF LYNCH AND HER MARKERS:
SEARCHING FOR IMMUNOHISTOCHEMICAL PATTERNS AMONG 113 TUMORS FROM 33 PATIENTS.
Acta Clin Croat. 2022;61:239-247.
PubMed
Abstract available
Appl Immunohistochem Mol Morphol
High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial
Carcinomas.
Appl Immunohistochem Mol Morphol. 2023;31:94-100.
PubMed
Abstract available
The status of bladder cancer research worldwide, a bibliometric review and
recommendations.
Arab J Urol. 2022;21:1-9.
PubMed
Abstract available
Salivary cotinine level and treatment response in muscle invasive bladder cancer:
A pilot study.
BJUI Compass. 2022;4:164-166.
PubMed
Systematic review of reported association studies of monogenic genes and bladder
cancer risk and confirmation analysis in a large population cohort.
BJUI Compass. 2022;4:156-163.
PubMed
Abstract available
Gross hematuria as the presentation of ureteral paraganglioma: a case report and
literature review.
BMC Urol. 2023;23:21.
PubMed
Abstract available
De novo upper tract urothelial carcinoma after renal transplantation: a
single-center experience in China.
BMC Urol. 2023;23:23.
PubMed
Abstract available
Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and
mitigates the radiation-induced CXCL1 signalling.
Br J Cancer. 2023 Feb 21. doi: 10.1038/s41416-023-02195.
PubMed
Abstract available
m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2
promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1
mRNAs splicing and stabilization.
Cell Death Dis. 2023;14:139.
PubMed
Abstract available
FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks
characterizing muscle invasive bladder cancer.
Commun Biol. 2023;6:199.
PubMed
Abstract available
Assessment of the Ecological Association between Tobacco Smoking Exposure and
Bladder Cancer Incidence over the Past Half-Century in the United States.
Curr Oncol. 2023;30:1986-1998.
PubMed
Abstract available
Re: A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder
Cancer.
Eur Urol. 2023 Feb 16:S0302-2838(23)02571-X. doi: 10.1016/j.eururo.2023.
PubMed
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guerin in
Patients with High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2023 Feb 15:S2588-9311(23)00032.
PubMed
Abstract available
Characterization of the tumor-infiltrating immune repertoire in muscle invasive
bladder cancer.
Front Immunol. 2023;14:986598.
PubMed
Abstract available
Single-cell RNA sequencing reveals the immune microenvironment and signaling
networks in cystitis glandularis.
Front Immunol. 2023;14:1083598.
PubMed
Abstract available
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich,
and neuroendocrine molecular and immunological features of muscle-invasive
bladder cancer.
Front Oncol. 2023;13:1120329.
PubMed
Abstract available
Corrigendum to "miR-3622a promotes proliferation and invasion of bladder cancer
cells by downregulating LASS2" [Gene 701 (2019) 23-31].
Gene. 2023;862:147266.
PubMed
Adjuvant intravesical chemohyperthermia or conventional chemotherapy in an era of
bacillus Calmette-Guerin shortage for non-muscle invasive bladder cancer: The
HIVEC-II trial.
Indian J Urol. 2023;39:75-76.
PubMed
The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a
retrospective review over 10 years period.
Infect Agent Cancer. 2023;18:10.
PubMed
Abstract available
Differences in overall survival of T2N0M0 bladder cancer patients vs.
population-based controls according to treatment modalities.
Int Urol Nephrol. 2023 Feb 23. doi: 10.1007/s11255-023-03517.
PubMed
Abstract available
GNRH family genes contributed to gender-specific disparity of bladder cancer
prognosis through exerting opposite regulatory roles between males and females.
J Cancer Res Clin Oncol. 2023 Feb 19. doi: 10.1007/s00432-023-04640.
PubMed
Abstract available
Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a
drug for benign prostate hyperplasia, in bladder cancer.
J Transl Med. 2023;21:129.
PubMed
Abstract available
p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to
Induce Ferroptosis in Bladder Cancer Cells.
Lab Invest. 2023;103:100058.
PubMed
Abstract available
Stellettin B Induces Cell Death in Bladder Cancer Via Activating the
Autophagy/DAPK2/Apoptosis Signaling Cascade.
Mar Drugs. 2023;21:73.
PubMed
Abstract available
CCNB2 as a potential biomarker of bladder cancer via the high throughput
technology.
Medicine (Baltimore). 2023;102:e32825.
PubMed
Abstract available
Identification and validation of the pyroptosis-related long noncoding rna
signature to predict the prognosis of patients with bladder cancer.
Medicine (Baltimore). 2023;102:e33075.
PubMed
Abstract available
Do perioperative blood transfusions impact oncological outcomes of robot-assisted
radical cystectomy with intracorporeal urinary diversion? Results from a large
multi-institutional registry.
Minerva Urol Nephrol. 2023;75:50-58.
PubMed
Abstract available
Tumor and stromal cell targeting with Nintedanib and Alpelisib overcomes
intrinsic bladder cancer resistance.
Mol Cancer Ther. 2023 Feb 20:MCT-21-0667. doi: 10.1158/1535-7163.MCT-21-0667.
PubMed
Abstract available
Prognostic value of the sarcomatoid component in bladder cancer: A propensity
score matching study.
Oncol Lett. 2023;25:103.
PubMed
Abstract available
[New WHO classification 2022: urinary bladder cancer].
Pathologie (Heidelb). 2023 Feb 24. doi: 10.1007/s00292-023-01183.
PubMed
Abstract available
Multimodal investigation of bladder cancer data based on computed tomography,
whole slide imaging, and transcriptomics.
Quant Imaging Med Surg. 2023;13:1023-1035.
PubMed
Abstract available
[Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of
the British BC2001 study].
Strahlenther Onkol. 2023 Feb 23. doi: 10.1007/s00066-023-02052.
PubMed
Selective inhibition of integrin alphavbeta6 leads to rapid induction of urinary bladder
tumors in cynomolgus macaques.
Toxicol Sci. 2023;191:400-413.
PubMed
Abstract available
Patterns of mutations in nine cancer-related genes and PAF development among
smoking male patients diagnosed with bladder cancer.
Tumour Biol. 2023;45:1-14.
PubMed
Abstract available
Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG
Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.
Urol Int. 2023 Feb 21:1-7. doi: 10.1159/000528740.
PubMed
Abstract available
Identification of the KIF and MCM protein families as novel targets for
combination therapy with CDK4/6 inhibitors in bladder cancer.
Urol Oncol. 2023 Feb 20:S1078-1439(23)00010.
PubMed
Abstract available
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with
non-muscle invasive bladder cancer after BCG failure.
World J Urol. 2023 Feb 22. doi: 10.1007/s00345-023-04332.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by